Abstract
Inside Precision MedicineVol. 10, No. 2 InterviewsBeyond Genomics: Proteomics-Based Companion Diagnostics for Precision MedicineDamian DohertyDamian DohertyDamian Doherty has been in media and publishing for nearly 30 years, beginning in the early nineties at News Corporation. Damian has managed, edited, and launched life science titles in drug discovery and precision medicine. He was features editor of Drug Discovery World for fourteen years and founded, established, and edited the Journal of Precision Medicine in 2014. In parallel, Damian founded and organized the Precision Medicine Leaders' Summit, a global, immersive 3-day senior leadership conference that still runs today. He edited AIMed magazine in 2019 before launching Photo51Media, a platform for illuminating untold, compelling stories in precision healthcare. Damian joined Mary Ann Liebert in 2021 to help steer the new rebrand and relaunch of Clinical OMICS to Inside Precision Medicine.Search for more papers by this authorPublished Online:12 Apr 2023https://doi.org/10.1089/ipm.10.02.11AboutSectionsView articleView Full TextPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View articleFiguresReferencesRelatedDetails Volume 10Issue 2Apr 2023 InformationCopyright © GEN PublishingTo cite this article:Damian Doherty.Beyond Genomics: Proteomics-Based Companion Diagnostics for Precision Medicine.Inside Precision Medicine.Apr 2023.42-44.http://doi.org/10.1089/ipm.10.02.11Published in Volume: 10 Issue 2: April 12, 2023PDF download
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
